Mr. Speaker, it is true that the federal government does not have much to do with health care, but what little it does, it should do properly. Transfers to Quebec and the provinces are one thing, but the list of unavailable drugs is also within the federal government's purview. Right now, drug company participation is voluntary. The minister can respond, but I believe that her government is receptive to the idea of making the list mandatory. That would help. A system to alert stakeholders about shortages is clearly within federal jurisdiction.
I would like to ask the minister one simple question. The FDA found a problem with one single product at the Sandoz plant, so why did it conclude that the entire pharmaceutical company was compromised? The government could talk to the U.S. government about that. There was a problem with one single product, a product that is not even used in Canada or Quebec. That is unbelievable.